Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group (Q79393410)
Jump to navigation
Jump to search
scientific article published on 28 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group |
scientific article published on 28 November 2006 |
Statements
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group (English)
Emiel Rutgers
Marzena Welnicka-Jaskiewicz
Leilani Morales
Peter Canney
Jaroslaw Dyczka
Robert Coleman
Tanja Cufer
Johan Nortier
Jan Bogaerts
Patrick Therasse
Robert Paridaens
European Organisation for Research and Treatment of Cancer Breast Group
Scottish Breast Cancer Trials Group
28 November 2006